Great Valley Advisor Group, Inc.
- SEC CIK
- 0001769897
- Latest filing
- Aug 10, 2026
MDNAF holding history
Medicenna Therapeutics Corp. in every 13F filed by Great Valley Advisor Group, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MDNAF overviewAll 13F holders of MDNAFFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q2 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −19,500−100.0% | Sold out | Holders |
| Q3 2023 | 19,500 | $5.75K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 19,500 | $9.39K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 19,500 | $12.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 19,500 | $8.93K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 19,500 | $16.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 19,500 | $23.0K | <0.1% | +19,500 | New | Holders |